This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM4T1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,342.88 Firm Fixed Price Delivery Order contract covers the supply of 4567059370 - VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with a performance period through January 28, 2025. The contract is not designated as a set-aside and represents an open competition award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,368.78 firm fixed-price delivery order is for VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with a completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6LUY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,025.33 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 160-25 mg tablets. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.03 firm-fixed-price delivery order is for the supply of 4567610035 - VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with a performance period ending on March 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNM45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,307.69, is for the delivery of 4566422561 ! VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 14,...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF9ZD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,515.51 firm fixed-price delivery order is for 4,567,887,041 units of the drug Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,917.45 firm fixed-price delivery order is for the supply of 4566477136 VALSARTAN-HCTZ 320-12.5 MG TAB 90S, with an ultimate completion date of November 19, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, with an ID of SPE2DB22D1017 and SPE2DB24FF9LS, is a Delivery Order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,466.09, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of June 13, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award SPE2DB24D2205|SPE2DB25FDWZA was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,656.64 firm fixed price contract is for the delivery of 4566947301 VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a type of prescription medication. The contract has an ultimate completion date of January 16, 2025. The award is not designated under any set-aside program....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,248.58, is for the supply of 4567790861 VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is April 4, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...